Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Mecca

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 1, 1985
Cerebral intraventricular 6-hydroxydopamine prevents vascular changes in the mineralocorticoid hypertensive ratT E Mecca, F S Lamb, J L Hall, et al.
European Journal of Pharmacology|May 2, 1980
alpha-Adrenergic blocking properties of quinine HClT E Mecca, J T Elam, C B Nash, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive ratsF J Fenoy, I Milicic, M Mistry, et al.
Diabetes Care|June 2, 2000
Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 DiabetesR E Ratner, I B Hirsch, J L Neifing, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 1, 1985
Cerebral intraventricular 6-hydroxydopamine prevents vascular changes in the mineralocorticoid hypertensive ratT E Mecca, F S Lamb, J L Hall, et al.
European Journal of Pharmacology|May 2, 1980
alpha-Adrenergic blocking properties of quinine HClT E Mecca, J T Elam, C B Nash, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive ratsF J Fenoy, I Milicic, M Mistry, et al.
Diabetes Care|June 2, 2000
Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 DiabetesR E Ratner, I B Hirsch, J L Neifing, et al.
Pageof 2